Zhongda Hospital
Nanjing, Jiangsu, 210009, China
NCT Number: NCT02814994
The Acute Respiratory Distress Syndrome (ARDS) is one of common clinical critically diseases. In the United States, the incidence of ARDS reaches 31%, which is one of the main causes of death in patients. There is no unified treatment process for ARDS currently and the treatment measures are not yet standardized, so the standardization of ARDS treatment processes is needed to reduce mortality in patients. Following the evidence-based medicine principles and six-step treatment standards of ARDS, this study uses the method of multi-center randomized controlled clinical trials to evaluate the standardized treatment process of ARDS, which provides the basis for the standardized treatment of ARDS.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Nanjing, Jiangsu, 210009, China
From September 1st 2012 to September 30th 2014, all ARDS patients admitted to the ICUs will be enrolled. The demographic characteristics, diagnosis, formerly medical history, Ventilator indications, Ventilator data, other respiratory treatments, weaning outcome and 28 day mortality will be recorded.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ventilated with tidal volume guided by respiratory system compliance
ventilation ventilated with low tidal volume
Time frame: 28-days
Southeast University, China
Other
Respiratory System Compliance Guided Tidal Volume in Moderate to Severe ARDS Patients: A Multicenter Randomized Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04291508
Acute Respiratory Distress Syndrome, Critical Illness
Birmingham, Alabama, United States
View Trial DetailsNCT04457505
Acute Respiratory Distress Syndrome, Infections
L'Hospitalet de Llobregat, Barcelona, Spain
View Trial DetailsNCT04357730
Acute Respiratory Distress Syndrome, COVID-19
La Jolla, California, United States
View Trial DetailsNCT03201263
Acute Respiratory Distress Syndrome, Lung Diseases
Beijing, China
View Trial Details